Background - Locations - Brussels

Pharma/Biotech Patent Litigation Conference

February 17 - 18, 2009 • Amsterdam, Netherlands

Expert practitioners with vast experience in managing complex patent litigation will provide practical and strategic advice on:

  • How to approach settlement agreements in the wake of uncertainty resulting from the EC Sector Inquiry
  • The current status of obviousness in the EU and US post KSR and Angiotech
  • Case law updates including HGS, Lundbeck and Esai v Dr Reddy's
  • Improving your approach to litigation across the EU through assessment of recent judicial decisions
  • Aligning your litigation strategy with corporate goals
  • Mastering the challenges of coordinating information flow and legal teams across borders during litigation

Sean-Paul Brankin will speak on "The EU Sector Inquiry: Implications for Patent Litigation and Settlements".

  • Review of the current climate: the impact of the Inquiry to date
  • The implications of the Commission’s Preliminary Report for patent litigation and settlement
  • What is the appropriate approach in this area pending the Final Report?
  • The role of anti-trust in the pharma sector going forward
Crowell & Moring Participant(s):
Sean-Paul Brankin
Partner – Brussels
Phone: +
For more information, please visit these areas: